EGFR and neoplasm: The enhanced growth of AnxA6-deficient tumor cells on the other hand is currently believed to be driven by the high cytosolic Ca2+-induced activation of PKC isoforms that in turn activate the Ras pathway independently of EGFR activity [20,23].